Evidence map›Paper›PMID 35687603›Full record

ArticlePloS one2022

Comprehensive clinical assessment identifies specific neurocognitive deficits in working-age patients with long-COVID.

David A Holdsworth, Rebecca Chamley, Rob Barker-Davies, Oliver O'Sullivan, Peter Ladlow, James L Mitchell, Dominic Dewson, Daniel Mills, Samantha L J May, Mark Cranley and 9 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 4 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 4 syntheses or guidelines pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Post-COVID-19 dyspnoea and pulmonary imaging: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2023
    Pooled it
  5. Article
  6. Excess all-cause mortality in Norway in 2024.Scandinavian journal of public health · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 1 country.

David A HoldsworthRoyal Centre for Defence Medicine Birmingham, Birmingham, United Kingdom.ORCID 0000-0003-2465-1521
Rebecca ChamleyAcademic Department of Military Medicine, Birmingham, United Kingdom.
Rob Barker-DaviesDefence Medical Rehabilitation Centre, Academic Department of Military Rehabilitation, Stanford Hall, United Kingdom.
Oliver O'SullivanDefence Medical Rehabilitation Centre, Academic Department of Military Rehabilitation, Stanford Hall, United Kingdom.ORCID 0000-0002-9184-4713
Peter LadlowDefence Medical Rehabilitation Centre, Academic Department of Military Rehabilitation, Stanford Hall, United Kingdom.
James L MitchellDefence Medical Rehabilitation Centre, Academic Department of Military Rehabilitation, Stanford Hall, United Kingdom.
Dominic DewsonDefence Medical Rehabilitation Centre, Academic Department of Military Rehabilitation, Stanford Hall, United Kingdom.
Daniel MillsDefence Medical Rehabilitation Centre, Academic Department of Military Rehabilitation, Stanford Hall, United Kingdom.
Samantha L J MayDefence Medical Rehabilitation Centre, Academic Department of Military Rehabilitation, Stanford Hall, United Kingdom.
Mark CranleyDefence Medical Rehabilitation Centre, Stanford Hall, United Kingdom.
Cheng XieOxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
Edward SellonOxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
Joseph MulaeRoyal Centre for Defence Medicine Birmingham, Birmingham, United Kingdom.
Jon NaylorRoyal Centre for Defence Medicine Birmingham, Birmingham, United Kingdom.
Betty RamanUniversity of Oxford, OCMR, Division of Cardiovascular Medicine, Oxford, United Kingdom.
Nick P TalbotOxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
Oliver J RiderUniversity of Oxford, OCMR, Division of Cardiovascular Medicine, Oxford, United Kingdom.
Alexander N BennettDefence Medical Rehabilitation Centre, Academic Department of Military Rehabilitation, Stanford Hall, United Kingdom.
Edward D NicolRoyal Centre for Defence Medicine Birmingham, Birmingham, United Kingdom.
University of Oxford · GBBirmingham Research Park · GBOxford University Hospitals NHS Trust · GBImperial College London · GBKing's College London · GBLoughborough University · GBUniversity of Bath · GBUniversity of Birmingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThere have been more than 425 million COVID-19 infections worldwide. Post-COVID illness has become a common, disabling complication of this infection. Therefore, it presents a significant challenge to global public health and economic activity.

methodsComprehensive clinical assessment (symptoms, WHO performance status, cognitive testing, CPET, lung function, high-resolution CT chest, CT pulmonary angiogram and cardiac MRI) of previously well, working-age adults in full-time employment was conducted to identify physical and neurocognitive deficits in those with severe or prolonged COVID-19 illness.

results205 consecutive patients, age 39 (IQR30.0-46.7) years, 84% male, were assessed 24 (IQR17.1-34.0) weeks after acute illness. 69% reported ≥3 ongoing symptoms. Shortness of breath (61%), fatigue (54%) and cognitive problems (47%) were the most frequent symptoms, 17% met criteria for anxiety and 24% depression. 67% remained below pre-COVID performance status at 24 weeks. One third of lung function tests were abnormal, (reduced lung volume and transfer factor, and obstructive spirometry). HRCT lung was clinically indicated in <50% of patients, with COVID-associated pathology found in 25% of these. In all but three HRCTs, changes were graded 'mild'. There was an extremely low incidence of pulmonary thromboembolic disease or significant cardiac pathology. A specific, focal cognitive deficit was identified in those with ongoing symptoms of fatigue, poor concentration, poor memory, low mood, and anxiety. This was notably more common in patients managed in the community during their acute illness.

conclusionDespite low rates of residual cardiopulmonary pathology, in this cohort, with low rates of premorbid illness, there is a high burden of symptoms and failure to regain pre-COVID performance 6-months after acute illness. Cognitive assessment identified a specific deficit of the same magnitude as intoxication at the UK drink driving limit or the deterioration expected with 10 years ageing, which appears to contribute significantly to the symptomatology of long-COVID.

Indexed as

COVID-19Acute DiseaseAdultFatigueFemaleHumansLungMalePost-Acute COVID-19 Syndrome

Identifiers

PMID35687603
PMCPMC9187094
OpenAlexW4281780364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.